XML 70 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Tax Provision

A summary of the Company’s current and deferred tax provision is as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Current income tax expense:

 

 

 

 

 

 

Federal

 

$

-

 

 

$

-

 

State

 

 

13

 

 

 

17

 

Total current income tax expense

 

 

13

 

 

 

17

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

Federal

 

 

1

 

 

 

1

 

State

 

 

(1

)

 

 

2

 

Total deferred tax expense

 

 

—

 

 

 

3

 

Total expense from income taxes

 

$

13

 

 

$

20

 

Schedule of Reconciliation of the U.S. Federal Statutory Income Tax

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Federal statutory income tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefits

 

 

(38.9

)%

 

 

9.8

%

Research and development tax credits

 

 

0.0

%

 

 

1.5

%

Interest accretion expense

 

 

(186.9

)%

 

 

8.6

%

Change in valuation allowance

 

 

269.1

%

 

 

(46.1

)%

Mark to market warrant

 

 

(58.5

)%

 

 

2.8

%

Deferred true-up

 

 

0.2

%

 

 

1.7

%

Stock-based compensation

 

 

(8.2

)%

 

 

0.5

%

Impairment

 

 

5.3

%

 

 

—

 

Other permanent items

 

 

(3.1

)%

 

 

0.2

%

Effective income tax rate

 

 

(0.0

)%

 

 

0.0

%

Schedule of Net Deferred Tax Liabilities

Net deferred tax liabilities as of December 31, 2022 and 2021 consisted of the following:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

102,723

 

 

$

88,327

 

Research and development tax credit carryforwards

 

 

5,674

 

 

 

7,672

 

Stock-based compensation expense

 

 

14,321

 

 

 

11,748

 

Startup costs

 

 

588

 

 

 

697

 

Intangible assets

 

 

3,905

 

 

 

4,471

 

Deferred revenue

 

 

1,135

 

 

 

1,103

 

Unicap

 

 

6

 

 

 

6

 

Imputed interest on contingent payments

 

 

5,654

 

 

 

4,410

 

Legal fee capitalization and amortization

 

 

1,342

 

 

 

1,550

 

Capitalized research and development

 

 

19,318

 

 

 

—

 

Other

 

 

3,121

 

 

 

1,535

 

Total deferred tax assets

 

 

157,787

 

 

 

121,519

 

Deferred tax liabilities:

 

 

 

 

 

 

In-process research and development

 

 

(27,271

)

 

 

(29,232

)

Total deferred tax liabilities

 

 

(27,271

)

 

 

(29,232

)

Valuation allowance

 

 

(130,525

)

 

 

(92,297

)

Net deferred tax liabilities

 

$

(9

)

 

$

(10

)

Schedule of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

 

 

Unrecognized
Tax Benefits

 

Balance at December 31, 2020

 

$

1,028

 

Increase related to current year tax provisions

 

 

242

 

Balance at December 31, 2021

 

$

1,270

 

Decrease related to current year tax provisions

 

 

(242

)

Balance at December 31, 2022

 

$

1,028